Heart Transplantation Allograft Vasculopathy | Treatment & Management | Point of Care
Coronary Collaterals Predict Improved Survival and Allograft Function in Patients With Coronary Allograft Vasculopathy | Circulation: Heart Failure
Cardiac Allograft Vasculopathy: An Ongoing Challenge in the Care of Heart Transplant Recipients (Chronic Rejection in Cardiac Transplantation) Part 1
e-heart.org Cardiovascular Pathology Home Page
Diagnostics | Free Full-Text | The Role of Echocardiography in the Management of Heart Transplant Recipients
Cardiac Allograft Vasculopathy (CAV) with UCSD - CardioNerds
PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy | Journal of the American College of Cardiology
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De‐novo heart transplant recipients: Design of the randomized controlled EVOLVD trial - Broch - 2020 - Clinical Transplantation - Wiley Online Library
Role of Quantitative Flow Ratio in Predicting Future Cardiac Allograft Vasculopathy in Heart Transplant Recipients | Circulation: Cardiovascular Interventions
Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation - ScienceDirect
Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events - ScienceDirect
Implementing Coronary CT for Routine Annual Surveillance of Cardiac Allograft Vasculopathy in Heart Transplant Patients - The Journal of Heart and Lung Transplantation
Cardiac Allograft Vasculopathy: An Ongoing Challenge in the Care of Heart Transplant Recipients | IntechOpen
Multiparametric Cardiac Magnetic Resonance Imaging Detects Altered Myocardial Tissue and Function in Heart Transplantation Recipients Monitored for Cardiac Allograft Vasculopathy
Established detection of CAV through its coronary sequelae. a An XRCA... | Download Scientific Diagram
Prophylactic use of mTOR inhibitors and other immunosuppressive agents in heart transplant patients | Cellular & Molecular Immunology
Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification | Virchows Archiv
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients - ScienceDirect
Cardiac allograft vasculopathy (CAV) superimposed on asymmetric native... | Download Scientific Diagram
Stanford classification of CAV severity on IVUS | Download Table
Imaging in Heart Transplant Patients | JACC: Cardiovascular Imaging
Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography | PLOS ONE
Transplantology | Free Full-Text | Multimodality Imaging to Detect Rejection, and Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients—An Illustrative Review
Cardiac allograft vasculopathy - Wikipedia
Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era - Journal of Cardiac Failure
